Inibidores
Os inibidores são moléculas que se ligam a enzimas, receptores ou outras proteínas para reduzir ou bloquear sua atividade biológica. Esses compostos são amplamente utilizados em pesquisas para estudar vias biológicas, entender mecanismos de doenças e desenvolver medicamentos terapêuticos. Os inibidores desempenham um papel crucial no tratamento de várias doenças, incluindo câncer, doenças cardiovasculares e infecções. Na CymitQuimica, oferecemos uma ampla gama de inibidores de alta qualidade para apoiar sua pesquisa em bioquímica, biologia celular e desenvolvimento farmacêutico.
Subcategorias de "Inibidores"
- Angiogénese(2.811 produtos)
- Apoptose(6.295 produtos)
- Ciclo celular/Ponto de verificação(4.842 produtos)
- Cromatina/Epigenética(2.526 produtos)
- Sinalização Citoesquelética(1.550 produtos)
- Dano de DNA/Reparo de DNA(2.917 produtos)
- Endocrinologia/Hormónios(3.708 produtos)
- Enzima(3.671 produtos)
- GPCR/Proteína-G(9.024 produtos)
- Imunologia e Inflamação(3.896 produtos)
- Vírus da Influenza(302 produtos)
- Sinalização JAK/STAT(418 produtos)
- Sinalização MAPK(1.248 produtos)
- Transportador de Membranas/Canal Iónico(3.094 produtos)
- Metabolismo(10.157 produtos)
- Microbiologia/Virologia(7.623 produtos)
- Neurociência(10.360 produtos)
- Outros inibidores(35.913 produtos)
- Oxidação-Redução(40 produtos)
- Sinalização PI3K/Akt/mTOR(1.440 produtos)
- Proteases/Proteassoma(1.711 produtos)
- Células - tronco e Derivados(792 produtos)
- Tirosina Quinase/Adaptador(2.013 produtos)
- Ubiquitinação(1.722 produtos)
Exibir 16 mais subcategorias
Foram encontrados 66619 produtos de "Inibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Cathepsin K inhibitor 2
CAS:Cathepsin K inhibitor 2 targets CTSK gene, may treat osteoporosis and osteoarthritis, detailed in patent WO2021147882A1.Fórmula:C30H33F4N5O3Cor e Forma:SolidPeso molecular:587.61JH-XVII-10
JH-XVII-10: potent, oral DYRK1A/B inhibitor (IC50: 3/5 nM), shows antitumor activity in HNSCC.Fórmula:C21H16F4N8OCor e Forma:SolidPeso molecular:472.4Antitubercular agent-13
Compound 3d: antitubercular, MIC 0.007 μg/mL vs MTB H37Rv, 1.851 μg/mL vs MDR-MTB 16833, metabolically unstable.Fórmula:C18H18N4O5Cor e Forma:SolidPeso molecular:370.36Plasma kallikrein-IN-2
Plasma kallikrein-IN-2: PKal inhibitor, IC50=0.1 nM. Used in angioedema, diabetic eye disease research.Fórmula:C28H24ClF3N8O3Cor e Forma:SolidPeso molecular:612.99Topo I/COX-2-IN-2
Compound W10 is a dual inhibitor of Topo I (IC50: 0.90μM) and COX-2 (IC50: 2.31μM), inducing cancer cell apoptosis via mitochondria.Fórmula:C24H25ClN4OCor e Forma:SolidPeso molecular:420.93AKT-IN-10
CAS:AKT-IN-10, a potent AKT inhibitor, has potential for breast and prostate cancer research, impacting cell growth and survival pathways.Fórmula:C26H34ClN5O2Cor e Forma:SolidPeso molecular:484.03HSV-TK substrate
CAS:HSV-TK substrate is a substrate for HSV-TK with antitumor activity. It induces multi-log cytotoxicity in HSV-TK-expressing and bystander cells.Fórmula:C11H15N5O4Pureza:98%Cor e Forma:SolidPeso molecular:281.27Anticancer agent 54
Anticancer agent 54 blocks cell cycle in G0/G1, induces apoptosis, and fights cancer via DNA embedding and ROS.Fórmula:C33H36N6Cor e Forma:SolidPeso molecular:516.68HPK1-IN-3
HPK1-IN-3: Selective HPK1 inhibitor, ATP-competitive, IC50=0.25nM; boosts IL-2 in PBMCs, EC50=108nM.Fórmula:C23H22F4N6O2Cor e Forma:SolidPeso molecular:490.45AS1940477
CAS:AS1940477 selectively inhibits p38 MAPK α/β, blocks proinflammatory cytokines in cells, and has anti-inflammatory effects in rats.Fórmula:C24H22FN5O2Cor e Forma:SolidPeso molecular:431.46EBOV-GP-IN-1
EBOV-GP-IN-1 (Compound 28) is a potent inhibitor of Ebola entry, acting on the Ebola virus envelope glycoprotein (EBOV-GP) (IC50: 0.05 μM).Fórmula:C25H40ClN3O2Cor e Forma:SolidPeso molecular:450.06CCG258747
CAS:CCG258747 is a novel, selective inhibitor of the GRK2 subfamily.Fórmula:C28H27FN4O4Cor e Forma:SolidPeso molecular:502.54L 731735
CAS:L 731735 is a farnesyltransferase inhibitor.Fórmula:C19H40N4O4SPureza:98%Cor e Forma:SolidPeso molecular:420.61Oral antiplatelet agent 1
CAS:Oral antiplatelet agent 1 is a potent antiplatelet agent with an IC50 of 2.94 μM in vitro.Fórmula:C23H24N4O5SPureza:98%Cor e Forma:SolidPeso molecular:468.53NVP-CGM097 sulfate
CAS:NVP-CGM097 sulfate is a potent and selective inhibitor of MDM2 (hMDM2, IC50 of 1.7±0.1 nM).Fórmula:C38H49ClN4O8SPureza:98%Cor e Forma:SolidPeso molecular:757.34AZD-4121 tert-butylammonium
CAS:AZD-4121 tert-butylammonium is an oral cholesterol absorption inhibitor targeting NPC1L1 for the treatment of dyslipidaemia.Fórmula:C40H50F2N4O7SCor e Forma:SolidPeso molecular:768.91LPM4870108
LPM4870108: Potent, oral pan-Trk inhibitor, selective over ALK, with anti-tumor effects. TrkC IC50=0.2nM, TrkA IC50=2.4nM.Fórmula:C20H19FN6O3Cor e Forma:SolidPeso molecular:410.4PDE-I2
CAS:PDE-I2 is a parasite schizogony inhibitor.Fórmula:C25H23N5O8Cor e Forma:SolidPeso molecular:521.48TGFβ1-IN-1
CAS:TGFβ1-IN-1 is a TGF-β1 inhibitor that inhibits the production of TGF-β1-induced fibrosis markers (α-SMA and fibronectin) and can be used in cancer research.Fórmula:C22H24N2O3Pureza:99.89% - 99.89%Cor e Forma:SolidPeso molecular:364.438Ref: TM-T61389
1mg50,00€5mg105,00€10mg170,00€25mg340,00€50mg557,00€100mg893,00€200mg1.198,00€1mL*10mM (DMSO)117,00€Heme Oxygenase-2-IN-1
Heme Oxygenase-2-IN-1 is a selective HO-2 inhibitor with IC50s: 14.9 μM (HO-1), 0.9 μM (HO-2).Fórmula:C19H17N3O2Cor e Forma:SolidPeso molecular:319.36Antitubercular agent-11
Antitubercular agent-11 (Compound 1e) is an antitubercular agent with a bulkier electron-donating group (Bu-t) that shows the best MIC value of 0.060 μg/mL [1].Fórmula:C16H15N3O4Cor e Forma:SolidPeso molecular:313.31Dexnebivolol
CAS:Dexnebivolol (R67138), a ß-adrenergic antagonist, is Nebivolol's enantiomer with β1 blocking and vasodilation properties.Fórmula:C22H25F2NO4Cor e Forma:SolidPeso molecular:405.43CP-199330
CAS:CP-199330: non-toxic alternative to Zafirlukast & Pranlukast, blocks cysteyl LT1 receptors.Fórmula:C28H24ClF3N2O6SCor e Forma:SolidPeso molecular:609.01Tonantzitlolone
CAS:Tonantzitlolone activates TRPC1/4/5 channels, PKCα/θ, inhibits IRS1/PI3K/AKT, and triggers HSF1 to induce glucose dependence.Fórmula:C26H40O7Cor e Forma:SolidPeso molecular:464.59SSR-182289A (Free)
CAS:SSR-182289A (Free) is a thrombin inhibitor.Fórmula:C30H33F2N5O4SPureza:98%Cor e Forma:SolidPeso molecular:597.68AChE-IN-24
AChE-IN-24: Strong AChE blocker, crosses blood-brain barrier, IC50=0.053 μM, useful for AD research.Fórmula:C22H30N2O4S2Cor e Forma:SolidPeso molecular:450.61DS88790512
CAS:DS88790512, IC50 at 11 nM, is an effective, selective, oral bioeffective TRPC6 inhibitor.Fórmula:C22H29N3O2Pureza:98%Cor e Forma:SolidPeso molecular:367.48Sunobinop
CAS:Sunobinop (S 117957) is an opioid receptor-like orphan receptor (ORL1) modulator.Fórmula:C26H33N3O3Cor e Forma:SolidPeso molecular:435.56BChE-IN-2
BChE-IN-2, a pyrimidine/pyridine derivative, potently inhibits BChE (Ki 0.099 μM) and shows promise in AD research.Fórmula:C22H31N5Cor e Forma:SolidPeso molecular:365.52Taprostene
CAS:Taprostene (CG-4203), a stable Prostacyclin analogue, protects endothelium and myocardium post-ischemia in cats, with minimal hemodynamic impact.Fórmula:C24H30O5Cor e Forma:SolidPeso molecular:398.49ROS1-IN-1
ROS1-IN-1, a potent ROS1 kinase inhibitor, has an IC50 of 0.097 μM.Fórmula:C17H15ClN6SCor e Forma:SolidPeso molecular:370.86MDL-100240
CAS:MDL-100240 inhibits ACE/neprilysin, effective against hypertension-induced heart/vascular changes.Fórmula:C26H28N2O5SPureza:98%Cor e Forma:SolidPeso molecular:480.58CB30865
CAS:CB30865 (ZM 242421) is a selective and highly effective nicotinamide phosphoribosyltransferase (Nampt) inhibitor with potential antitumor activity.Fórmula:C26H22BrN5O2Pureza:99.04%Cor e Forma:SolidPeso molecular:516.39DNA gyrase B-IN-1
DNA gyrase B-IN-1, a potent inhibitor of P. aeruginosa DNA gyrase B, has IC50 of 2.2 μM with high affinity and stability.Fórmula:C23H18ClF3N6O4SCor e Forma:SolidPeso molecular:566.94ONO-8809
CAS:ONO-8809: Thromboxane A2 antagonist, reduces airway hyperresponse, macrophage accumulation, and MMP-9 in SHRSP brains.Fórmula:C30H46BrNO4SPureza:98%Cor e Forma:SolidPeso molecular:596.66EGFR-IN-17
EGFR-IN-17: potent, selective EGFR inhibitor, IC50 of 0.2 nM, overcomes C797S drug resistance.Fórmula:C27H31ClN7O3PCor e Forma:SolidPeso molecular:568.01(Rac)-OSMI-1
(Rac)-OSMI-1, a racemate, inhibits OGT (IC50: 2.7 μM) affecting O-GlcNAcylation without changing surface glycans.Fórmula:C28H25N3O6S2Cor e Forma:SolidPeso molecular:563.64Mifepristone methochloride
CAS:Mifepristone methochloride is a glucocorticoid antagonist. This product will be sold for research use only.Fórmula:C30H38ClNO2Cor e Forma:SolidPeso molecular:480.08LXRβ agonist-3
CAS:LXRβ agonist-3 is a potent and selective LXRβ (liver X receptor β) agonist (EC50: 0.095 μM).Fórmula:C30H33N3O6SCor e Forma:SolidPeso molecular:563.66Ranakinin
CAS:Ranakinin is a novel tachykinin receptor agonist; from the brain of frog, Rana ridibunda.Fórmula:C62H95N17O15SCor e Forma:SolidPeso molecular:1350.59Ornoprostil
CAS:Ornoprostil, a prostaglandin E1 analogue, acts as a mucosal protectant.Fórmula:C23H38O6Pureza:98%Cor e Forma:SolidPeso molecular:410.54GSK1820795A
CAS:GSK1820795A: Telmisartan analog, selective hGPR132a antagonist, blocks yeast activation by N-acylamides, angiotensin II antagonist, partial PPARγ agonist.Fórmula:C35H34N8Cor e Forma:SolidPeso molecular:566.7K203
K203 is a potent tabun-inhibited AChE reactivator and is an important antidote to organophosphorus poisoning.Fórmula:C16H18Br2N4O2Cor e Forma:SolidPeso molecular:458.15AT-IAP
CAS:AT-IAP is an effective dual antagonist of XIAP and cIAP1.Fórmula:C29H40FN5O2Pureza:98%Cor e Forma:SolidPeso molecular:509.66FNC-TP trisodium
FNC-TP trisodium, active intracellular FNC form, inhibits NRTI, fights HIV, HBV, and HCV.Fórmula:C9H11FN6Na3O13P3Cor e Forma:SolidPeso molecular:592.11Antitubercular agent-22
Antitubercular agent-22 combats Candida albicans (MIC: 2.34 μg/ml) and M. tuberculosis (MIC: 2 μg/ml).Fórmula:C24H28FN5O8Cor e Forma:SolidPeso molecular:533.51Hsp90-IN-16
Hsp90-IN-16, a selective HSP90 inhibitor, targets HER2+ cancers with 6 μM IC50 in HCC1954 cells, blocking client proteins and inducing apoptosis.Fórmula:C30H26FN3O6Cor e Forma:SolidPeso molecular:543.54BW A868C
CAS:BW A868C is a potent, selective PGD2 antagonist and a BW245C analogue, inert to other prostaglandin receptors.Fórmula:C25H37N3O5Cor e Forma:SolidPeso molecular:459.58Antibacterial agent 81
CAS:Antibacterial agent 81 blocks DNA transcription, targets S. aureus (MIC 12.5μM) & M. smegmatis (MIC 7.8μM). Used in infection research.Fórmula:C33H28N2O8Cor e Forma:SolidPeso molecular:580.58EGFR-IN-38
CAS:EGFR-IN-38: low-toxic acrylamide-derived EGFR inhibitor, targets NSCLC, patented for research on EGFR mutation-related diseases.Fórmula:C25H24ClN7O2Cor e Forma:SolidPeso molecular:489.96MK-8318
CAS:MK-8318 is an effective and selective antagonist of the CRTh2 receptor (Ki: 5.0 nM).Fórmula:C27H26F4N2O5Pureza:98%Cor e Forma:SolidPeso molecular:534.517β-HSD1-IN-1
17β-HSD1-IN-1 (Compound 1) can be used in the non-small cell lung cancer (NSCLC) research.Fórmula:C21H21NO3Cor e Forma:SolidPeso molecular:335.4PptT-IN-3
PptT-IN-3 (5p), an inhibitor of PptT in Mycobacterium tuberculosis, IC50=3.5μM, is key for TB research.Fórmula:C16H27N5O3SCor e Forma:SolidPeso molecular:369.48LGB-321 HCl
CAS:LGB-321: potent, selective PIM kinase inhibitor, active against PIM2, halts diverse blood cancers' growth, orally effective in mice.Fórmula:C23H23ClF3N5O2Cor e Forma:SolidPeso molecular:493.91PD-1-IN-17 TFA
PD-1-IN-17 TFA is a potent PD-1 inhibitor, blocking 92% of splenocyte growth at 100 nM.Fórmula:C15H23F3N6O9Cor e Forma:SolidPeso molecular:488.37APN/AKT-IN-1
APN/AKT-IN-1, a dual APN (IC50=0.21μM) & AKT (IC50=0.27μM) inhibitor, hinders GSK3β phosphorylation.Fórmula:C18H27N7O3Cor e Forma:SolidPeso molecular:389.45Antitumor agent-37
Antitumor agent-37: strong anti-growth, anti-spread, induces DNA damage, apoptosis via Bcl-2/Bax/caspase3, boosts immune response.Fórmula:C16H18Cl2N2O4PtCor e Forma:SolidPeso molecular:568.32SCO-792
SCO-792: potent, reversible oral enteropeptidase inhibitor, with slow in vitro dissociation and in vivo protein digestion blocking.Fórmula:C22H22N4O8·xH2OCor e Forma:SolidAMS-17
AMS-17, a strong NLRP3 inhibitor, quells microglia activation and cytokines like caspase-1, TNF-α, IL-1β, iNOS in studies.Fórmula:C15H13F3N4O3SCor e Forma:SolidPeso molecular:386.35E7090 succinate
CAS:E7090 succinate inhibits FGFR1, FGFR2, and FGFR3 with IC50: 0.71, 0.50, 1.2 nM; less so FGFR4 at 120 nM.Fórmula:C76H92N10O24Cor e Forma:SolidPeso molecular:1529.60Deoxyfuconojirimycin hydrochloride
CAS:Deoxyfuconojirimycin hydrochloride acts as a specific competitive inhibitor targeting human liver α-L-fucosidase.Fórmula:C6H14ClNO3Cor e Forma:SolidPeso molecular:183.63Cav 3.2 inhibitor 3
Cav 3.2 inhibitor 3 is a potent inhibitor of the Cav3.2 T-type Ca2+channel (IC50: 0.1534 μM) and has a low binding affinity for D2 receptors.Fórmula:C32H37N3O2Cor e Forma:SolidPeso molecular:495.66AChE-IN-22
AChE-IN-22 (10q) selectively inhibits AChE (IC50: 0.88 μM), less on BuChE (IC50: 10 μM), targets CAS and PAS, useful in Alzheimer's research.Fórmula:C21H20N4O5SCor e Forma:SolidPeso molecular:440.47Scytonemin
CAS:Scytonemin, a cyanobacterial pigment, inhibits cancer cell growth by decreasing Plk1 activity, especially effective on U266 myeloma cells.Fórmula:C36H20N2O4Cor e Forma:SolidPeso molecular:544.55HDAC2-IN-1
HDAC2-IN-1 is an oral HDAC2 inhibitor (IC50: 0.5 μM), crosses the blood-brain barrier, and inhibits HDAC1 and HDAC8.Fórmula:C22H23ClN4OSCor e Forma:SolidPeso molecular:426.96MMSET-IN-1
CAS:MMSET-IN-1 is an inhibitor of multiple myeloma SET domain (MMSET, aka NSD2/WHSC1) .Fórmula:C18H29N7O5Pureza:98%Cor e Forma:SolidPeso molecular:423.47L5-DA
L5-DA, a G-quadruplex ligand, stabilizes G4s in HeLa cells, induces apoptosis, and is cytotoxic with an IC50 of 4.3 μM.Fórmula:C32H34N6O2Cor e Forma:SolidPeso molecular:534.65TS010
TS010 is a highly potent inhibitor of GLO-I, with an IC50 value of 0.57 μM. It holds significant promise for advancements in cancer research [1].Fórmula:C16H12N4O4SCor e Forma:SolidPeso molecular:356.36TCMDC-125431
TCMDC-125431 is a novel inhibitor of Plasmodium calcium kinetics with minimal inhibition of haemoglobin crystals.Fórmula:C25H27N3O2SCor e Forma:SolidPeso molecular:433.57Galidesivir
CAS:Galidesivir (BCX4430) is an antiviral compound that inhibits viral RNA-dependent RNA polymerase (RdRp) activity and reduces lung infections in infected animals.Fórmula:C11H15N5O3Pureza:96.73% - 99.13%Cor e Forma:SolidPeso molecular:265.27SC-435 mesylate
CAS:SC-435 is an ileal apical sodium co-dependent bile acid transporter (ASBT). SC-435 inhibits plasma cholesterol.Fórmula:C37H59N3O7S2Pureza:98%Cor e Forma:SolidPeso molecular:722.01T-3764518
CAS:T-3764518 is a novel and potent inhibitor of stearoyl coenzyme A desaturase (SCD)(IC50 of 4.7 nM).Fórmula:C20H17F6N5O2Pureza:98%Cor e Forma:SolidPeso molecular:473.37DNA Gyrase-IN-1
DNA Gyrase-IN-1: potent, selective promoter inhibitor. IC50: 2.6 μM, inhibits Mtb, MIC: 0.49 μM. Useful for tuberculosis research.Fórmula:C24H24FN7O6Cor e Forma:SolidPeso molecular:525.49ABD957
CAS:ABD957: covalent ABHD17 depalmitoylases inhibitor, IC50 0.21µM for ABHD17B, blocks N-Ras, halts NRAS-mutant AML cell growth.Fórmula:C27H36F3N7O5SCor e Forma:SolidPeso molecular:627.68CCG258208
CAS:GRKs-IN-1 has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM).Fórmula:C24H25FN4O4Pureza:98%Cor e Forma:SolidPeso molecular:452.48Nurr1 agonist 1
Nurr1 agonist 1 is an inverse agonist tool for the neuroprotective transcription factor Nurr1 which is an appealing target to treat neurodegenerative diseases.Fórmula:C16H14N2O2Cor e Forma:SolidPeso molecular:266.29NB-533
CAS:NB-533 is a macrocyclic peptidic BACE-1 inhibitor.Fórmula:C33H55N3O4Cor e Forma:SolidPeso molecular:557.81DNA crosslinker 4 dihydrochloride
CAS:DNA Crosslinker 4 binds DNA's minor groove, inhibits NCI-H460, A2780, MCF-7 cancer cells, and is used in cancer research.Fórmula:C16H24Cl2N8OCor e Forma:SolidPeso molecular:415.32CYP2C19-IN-1
CYP2C19-IN-1: potent CYP2C19 inhibitor, non-genotoxic, non-hepatotoxic, blocks RdRP (Ki: 6.16 μM), useful for ZIKV research.Fórmula:C26H26N2O6SCor e Forma:SolidPeso molecular:494.56Latrunculin M
CAS:Latrunculin M, a novel marine toxin, disrupts microfilament organization in cultured cells.Fórmula:C21H33NO5SCor e Forma:SolidPeso molecular:411.55OUN58101
CAS:OUN58101, also MDK-8101/BI-D, is an RSV L-protein inhibitor with no formal name, first reported in patent WO 2005042530.Fórmula:C32H36N6O6Cor e Forma:SolidPeso molecular:600.66Haspin-IN-2
CAS:Haspin-IN-2 is a potent haspin inhibitor (IC50: 50 nM) and also inhibits CLK1 (IC50: 445 nM) and DYRK1A (IC50: 917 nM).Fórmula:C12H8N4O3Cor e Forma:SolidPeso molecular:256.22BAY-364
CAS:BAY-364 (BAY-299N) functions as an inhibitor targeting the second bromine domain in TAF1, demonstrating inhibitory effects on TAF1 in Kasumi-1 cells, CD34+Fórmula:C23H19N3O4Cor e Forma:SolidPeso molecular:401.41VEGFR-2-IN-16
VEGFR-2-IN-16 (Compound 15b) is a potent inhibitor of VEGFR-2 (IC50: 86.36 nM) that exhibits antitumour effects.Fórmula:C21H13Cl2N3O2Cor e Forma:SolidPeso molecular:410.25Thielavin B
CAS:Thielavin B, from Thielavia terricola, inhibits prostaglandin E2 synthesis and reduces rat oedema.Fórmula:C31H34O10Cor e Forma:SolidPeso molecular:566.6(R)-CSN5i-3
CAS:(R)-CSN5i-3 is CSN5i-3 of the R configuration.Fórmula:C28H29F2N5O2Pureza:99.76% - 99.97%Cor e Forma:SolidPeso molecular:505.56L 668411
CAS:L 668411, the 2,3-ditritiated methyl ester of L 659699, inhibits HMG-CoA synthase.Fórmula:C19H30O5Pureza:98%Cor e Forma:SolidPeso molecular:338.44Pibrozelesin
CAS:Pibrozelesin, a water-soluble duocarmycin B2 derivative, binds AT-rich DNA, blocking replication and inducing cell death.Fórmula:C32H36BrN5O8Cor e Forma:SolidPeso molecular:698.56LSD1-IN-18
LSD1-IN-18 inhibits LSD1 (Ki: 0.156 μM, KD: 0.075 μM), blocking THP-1 and MDA-MB-231 cell growth (IC50: 0.16, 0.21 μM).Fórmula:C31H40N6O2Cor e Forma:SolidPeso molecular:528.69Anti-Aβ agent 1A
Anti-Aβ agent 1A is a potent anti-amyloid-β agent.Fórmula:C35H49NO4Cor e Forma:SolidPeso molecular:547.77TMC353121
CAS:TMC353121 is an effective inhibitor of respiratory syncytial virus fusion (pEC50: 9.9).Fórmula:C32H42N6O3Pureza:≥98%Cor e Forma:SolidPeso molecular:558.71Cdc7-IN-8
CAS:Cdc7-IN-8, inhibits Cdc7 kinase, key in DNA replication, and is promising for cancer research. (WO2021032170A1)Fórmula:C19H21N5O2Cor e Forma:SolidPeso molecular:351.40D-473
CAS:D-473 is a novel orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Fórmula:C26H27F2NO3Cor e Forma:SolidPeso molecular:439.49NYX-2925
CAS:NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. Useful for CNS disorder studies.Fórmula:C14H23N3O4Cor e Forma:SolidPeso molecular:297.35Antibacterial agent 113
Antibacterial agent 113 targets multiple bacteria including P. aeruginosa and E. coli, showing efficacy at MIC 15625 μM.Fórmula:C29H18ClN5OCor e Forma:SolidPeso molecular:487.94Aurora inhibitor 1
CAS:Aurora inhibitor 1 is a potent Aurora inhibitor (IC50: ≤ 4 nM and ≤13 nM for Aurora A and Aurora B kinase).Fórmula:C23H25N9SPureza:98%Cor e Forma:SolidPeso molecular:459.57Tarloxotinib bromide
CAS:Tarloxotinib bromide (TH-4000) is an irreversible inhibitor of EGFR/HER2.Fórmula:C24H24Br2ClN9O3Pureza:99.52%Cor e Forma:SolidPeso molecular:681.77Ref: TM-T13088
1mg133,00€5mg268,00€10mg409,00€25mg670,00€50mg888,00€100mg1.243,00€1mL*10mM (DMSO)414,00€Antibiotic MA 144M2
CAS:Antibiotic MA 144M2, an anthracycline glycoside, targets gram-positive bacteria and tumors, derived from Streptomyces and aclacinomycin A conversion.Fórmula:C42H55NO16Cor e Forma:SolidPeso molecular:829.88ABL-L
CAS:ABL-L is able to induce apoptosis in human laryngeal cancer cells using a p53-dependent pathway.Fórmula:C29H46O6Cor e Forma:SolidPeso molecular:490.67
